[US-헬스케어] 10/15 Wall St. Recap
LLYBULL As a senior equity analyst, I view Eli Lilly and Company ((LLY)) as maintaining a robust market position, reinforced by recent regulatory approvals and its emerging role as a (Safe Haven) asset amidst macroeconomic volatility. Despite significant historical gains,…